Tokyo, Sept. 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059023) titled 'Retrospective Analysis of Surgical Treatment of Lymphedema' on Sept. 7.
Study Type:
Observational
Primary Sponsor:
Institute - Keio University
Condition:
Condition - Lymphedema
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study was to collect and analyze postoperative data on lymphedema patients.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1. Patients diagnosed with lymphedema who underwent surgical treatment for lymphedema.
2. Patients diagnosed with lymphedema who declined surgical treatment and are currently under observation.
Key exclusion criteria - 1. Cases where the subject or their authorized representative expressed refusal to participate in this study
2. Other cases deemed unsuitable as research subjects by the responsible investigator
Target Size - 200
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2022 Year 06 Month 27 Day
Date of IRB - 2022 Year 06 Month 27 Day
Anticipated trial start date - 2022 Year 06 Month 27 Day
Last follow-up date - 2032 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067501
Disclaimer: Curated by HT Syndication.
